Guangdong Guanchi Stem Cell Medical Technology completed a Series A financing of 40 million yuan.

36Kr learned that on June 18, Guangdong Guanchi Stem Cell Medical Technology Co., Ltd. announced the completion of a 40 - million - yuan Series A financing round. This round of financing was led by Fuxing Capital, with institutions such as Chuangfu Capital and Zaoxingren Venture Capital participating as follow - on investors. The funds from this financing will strongly promote the R & D of core stem cell technologies and pipeline clinical R & D, as well as expand the R & D platform for innovative bio - based materials (used in cell culture, tissue engineering, etc.).